Qingdao NovelBeam Technology Co. Ltd. A Asset Resilience Ratio

Latest as of March 2026: 2.66%

Qingdao NovelBeam Technology Co. Ltd. A asset resilience ratio. Qingdao NovelBeam Technology Co. Ltd. A (688677) has an Asset Resilience Ratio of 2.66% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Qingdao NovelBeam Technology Co. Ltd. A balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥43.22 Million
≈ $6.32 Million USD Cash + Short-term Investments

Total Assets

CN¥1.63 Billion
≈ $237.83 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Qingdao NovelBeam Technology Co. Ltd. A (2023–2025)

Asset resilience ratio of Qingdao NovelBeam Technology Co. Ltd. A from 2023 to 2025. This chart shows how Qingdao NovelBeam Technology Co. Ltd. A's Asset Resilience Ratio has changed over time. See Qingdao NovelBeam Technology Co. Ltd. A free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Qingdao NovelBeam Technology Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Qingdao NovelBeam Technology Co. Ltd. A (688677) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥43.22 Million 2.66%
Total Liquid Assets CN¥43.22 Million 2.66%

Asset Resilience Insights

  • Limited Liquidity: Qingdao NovelBeam Technology Co. Ltd. A maintains only 2.66% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Qingdao NovelBeam Technology Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Qingdao NovelBeam Technology Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOYA CORP. ADR/ 1 O.N.
F:HYB0
Medical Instruments & Supplies 0.37%
Autek China Inc
SHE:300595
Medical Instruments & Supplies 21.20%
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
Mingyue Optical Lens Co.Ltd.
SHE:301101
Medical Instruments & Supplies 47.21%
Medeon Biodesign
TWO:6499
Medical Instruments & Supplies 32.68%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Nextgen
TA:NXGN
Medical Instruments & Supplies 3.13%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%

Qingdao NovelBeam Technology Co. Ltd. A Asset Resilience Ratio by Year (2023–2025)

Qingdao NovelBeam Technology Co. Ltd. A asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for Qingdao NovelBeam Technology Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 2.67% CN¥43.57 Million
≈ $6.38 Million
CN¥1.63 Billion
≈ $239.21 Million
-0.09pp
2023-12-31 2.76% CN¥38.45 Million
≈ $5.63 Million
CN¥1.39 Billion
≈ $204.11 Million
--
pp = percentage points

About Qingdao NovelBeam Technology Co. Ltd. A

SHG:688677 China Medical Instruments & Supplies
Market Cap
$856.04 Million
CN¥5.85 Billion CNY
Market Cap Rank
#9194 Global
#2196 in China
Share Price
CN¥48.80
Change (1 day)
-4.71%
52-Week Range
CN¥36.31 - CN¥154.98
All Time High
CN¥154.98
About

Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more